Juan C. Jaen - Net Worth and Insider Trading
Juan C. Jaen Net Worth
The estimated net worth of Juan C. Jaen is at least $26 Million dollars as of 2024-11-29. Juan C. Jaen is the President of Arcus Biosciences Inc and owns about 1,529,708 shares of Arcus Biosciences Inc (RCUS) stock worth over $24 Million. Juan C. Jaen is also the SVP, Drug Discovery & CSO of ChemoCentryx Inc and owns about 30,000 shares of ChemoCentryx Inc (CCXI) stock worth over $2 Million. Details can be seen in Juan C. Jaen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Juan C. Jaen has not made any transactions after 2024-02-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Juan C. Jaen
Juan C. Jaen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Juan C. Jaen owns 2 companies in total, including Arcus Biosciences Inc (RCUS) , and ChemoCentryx Inc (CCXI) .
Click here to see the complete history of Juan C. Jaen’s form 4 insider trades.
Insider Ownership Summary of Juan C. Jaen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RCUS | Arcus Biosciences Inc | 2024-02-27 | director & 10 percent owner & President |
| CCXI | ChemoCentryx Inc | 2013-03-08 | SVP & Drug Discovery & CSO |
Juan C. Jaen Latest Holdings Summary
Juan C. Jaen currently owns a total of 2 stocks. Among these stocks, Juan C. Jaen owns 1,529,708 shares of Arcus Biosciences Inc (RCUS) as of February 27, 2024, with a value of $24 Million and a weighting of 93.94%. Juan C. Jaen also owns 30,000 shares of ChemoCentryx Inc (CCXI) as of March 8, 2013, with a value of $2 Million and a weighting of 6.06%.
Latest Holdings of Juan C. Jaen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RCUS | Arcus Biosciences Inc | 2024-02-27 | 1,529,708 | 15.80 | 24,169,386 |
| CCXI | ChemoCentryx Inc | 2013-03-08 | 30,000 | 51.99 | 1,559,700 |
Holding Weightings of Juan C. Jaen
Juan C. Jaen Form 4 Trading Tracker
According to the SEC Form 4 filings, Juan C. Jaen has made a total of 6 transactions in Arcus Biosciences Inc (RCUS) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Arcus Biosciences Inc is the sale of 27,032 shares on February 27, 2024, which brought Juan C. Jaen around $543,073.
According to the SEC Form 4 filings, Juan C. Jaen has made a total of 0 transactions in ChemoCentryx Inc (CCXI) over the past 5 years. The most-recent trade in ChemoCentryx Inc is the sale of 2,795 shares on March 8, 2013, which brought Juan C. Jaen around $39,046.
Insider Trading History of Juan C. Jaen
- 1
Juan C. Jaen Trading Performance
GuruFocus tracks the stock performance after each of Juan C. Jaen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Juan C. Jaen is 3.82%. GuruFocus also compares Juan C. Jaen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Juan C. Jaen within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Juan C. Jaen's insider trading performs compared to the benchmark.
Performance of Juan C. Jaen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.65 | | | | | |
| Relative Return to S&P 500(%) | 6.34 | | | | | |
Juan C. Jaen Ownership Network
Juan C. Jaen Owned Company Details
What does Arcus Biosciences Inc do?
Who are the key executives at Arcus Biosciences Inc?
Juan C. Jaen is the director & 10 percent owner & President of Arcus Biosciences Inc. Other key executives at Arcus Biosciences Inc include Chief Accounting Officer Alexander Azoy , See Remarks Jennifer Jarrett , and 10 percent owner Gilead Sciences Inc .
Arcus Biosciences Inc (RCUS) Insider Trades Summary
Over the past 18 months, Juan C. Jaen made 2 insider transaction in Arcus Biosciences Inc (RCUS) with a net sale of 34,007. Other recent insider transactions involving Arcus Biosciences Inc (RCUS) include a net sale of 196,515 shares made by Jennifer Jarrett , a net purchase of 16,248,095 shares made by Gilead Sciences Inc , and a net sale of 6,053 shares made by Goeltz Ii Robert C. .
In summary, during the past 3 months, insiders sold 0 shares of Arcus Biosciences Inc (RCUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,214 shares of Arcus Biosciences Inc (RCUS) were sold and 16,248,095 shares were bought by its insiders, resulting in a net purchase of 16,009,881 shares.
Arcus Biosciences Inc (RCUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arcus Biosciences Inc Insider Transactions
Juan C. Jaen Mailing Address
Above is the net worth, insider trading, and ownership report for Juan C. Jaen. You might contact Juan C. Jaen via mailing address: 850 Maude Avenue, Mountain View Ca 94043.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
